AstraZeneca purchases former Amgen US facility
September 15, 2015Manufacturing and Production Amgen, AstraZeneca, US, biologics, manufacturing, production
AstraZeneca has bolstered its US presence with the purchase of a high-tech biologics manufacturing facility from pharma rival Amgen. The …
PureTech appoints Michael MacLean as chief financial officer
September 14, 2015Medical Communications, Research and Development, Sales and Marketing Michael MacLean, PureTech Health
PureTech Health has appointed Michael MacLean to the management team, as chief financial officer and executive vice president. Michael MacLean …
Counting the true cost of the Cancer Drugs Fund cuts
September 14, 2015Research and Development Cancer, Cancer Drugs Fund, NHS, clinical trials, cuts, oncology
Leading figures from the pharma industry and cancer charities reacted with dismay to the recent cuts to the Cancer Drugs …
FDA strengthens safety warning for J&J’s diabetes drug Invokana
September 14, 2015Sales and Marketing FDA, Food and Drugs Administration, Invokamet, J&J, JJ, Johnson & Johnson, diabetes, invokana, safety warning, type 2 diabetes
Johnson & Johnson has suffered a blow after the FDA strengthened its safety warning for the company’s type 2 diabetes …
Janssen submits EMA application for myeloma drug
September 14, 2015Sales and Marketing Janssen, daratumumab, multiple myeloma
Janssen has submitted a new marketing authorisation application for European approval of daratumumab for the treatment of patients with relapsed …
Boehringer earns NICE nod for IPF drug Ofev
September 14, 2015Sales and Marketing Boehringer Ingelheim, IPF, NICE, idiopathic pulmonary fibrosis
NICE has recommended Boehringer Ingelheim’s Ofev as a treatment for idiopathic pulmonary fibrosis after the German firm agreed to a …
The making of a modern pharma blockbuster
September 11, 2015Medical Communications Big Pharma, Twice Circled, computer game
The pharma industry divides opinions on its morality, but what has always stood out is the fact that in this …
US FDA accepts first digital medicine application
September 11, 2015Medical Communications FDA, NDA, Otsuka, digital, digital medicine, proteus
The FDA has accepted the first New Drug Application for a digital medicine: Otsuka and Proteus Digital Health’s collaboration of …
Supply chain leaders call for forward pharma thinking
September 11, 2015Manufacturing and Production, Medical Communications fly pharma, fly pharma conference, logistics, supply chain
Logistics companies must improve their understanding of the pharma industry to better serve their customers, according to a supply chain …
Envision Pharma acquires two medical education specialists in takeover deal
September 11, 2015Medical Communications
Two principals from Alligent Biopharm Consulting have joined the UK communications group Envision Pharma following an acquisition deal.Alligent’s two principals, …
Medimmune and Cancer Research UK launch new drug discovery lab
September 11, 2015Research and Development AstraZeneca, Cambridge, Cancer, Cancer Research UK, MedImmune, R&D, george freeman
MedImmune and the UK’s biggest cancer charity have opened a new laboratory for joint cancer research.Research at the laboratory, which …
Pfizer in metabolic disease push
September 11, 2015Medical Communications, Research and Development AMRA, Pfizer, UK Biobank, med tech, metabolic disease, obesity
Pfizer has signed a research collaboration with a global medical health technology company, to investigate risk factors for metabolic conditions. …
Actelion confirms takeover talks with ZS Pharma
September 11, 2015Research and Development, Sales and Marketing Actelion, Shire, ZS Pharma, mergers and acquisitions
Swiss drugmaker Actelion has entered discussions with US biotech company ZS Pharma, over a takeover thought to be worth $2.5 …
High Court rules against Pfizer in Lyrica patent case
September 10, 2015Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin
The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …
EM Imaging appoints new chairman
September 10, 2015Manufacturing and Production, Research and Development EM Imaging, Optometry, ophthalmology
The board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans as non-executive …
Featured market report: Healthcare mobility solutions market by products and services, global forecast to 2020
September 10, 2015Manufacturing and Production, Medical Communications, Sales and Marketing apps, healthcare mobility, market report, mobile healthcare, smartphones
The global healthcare mobility solutions market is set to grow by as much as 30% to 2020, as the healthcare …
Lung cancer market to hit $10.9bn by 2021
September 10, 2015Sales and Marketing AZD9291, GBI Research, GlobalData, NSCLC, industry analysis, industry intelligence, industry reports, keytruda, market intelligence lung cancer, market reports, market trends, non small cell lung cancer, non-small cell lung cancer, opdivo, world conference on lung cancer
The global market value for non-small cell lung cancer treatment will rise from $6.9 billion in 2014 to $10.9 billion …
Mylan to relaunch $27.1bn hostile takeover of Perrigo
September 10, 2015Sales and Marketing Mylan Perrigo, acquisitions, hostile bid, mergers, takeover
Mylan is to make yet another hostile $27.1 billion bid for Irish over the counter drug manufacturer Perrigo on Monday, …
Gilead’s Truvada prevents HIV infections in high-risk men
September 10, 2015Research and Development Gilead, HIV, PrEP, Truvada, pre-exposure prophylaxis treatment, sexually transmitted infections
UK researchers say Truvada, Gilead’s HIV prevention treatment, should be added to the country’s ‘HIV prevention toolkit’, after a study …
GSK begins work on £100m India facility
September 9, 2015Manufacturing and Production GlaxoSmithKline, India, manufacturing
GSK has begun work on its new Rs. 1000 crore (£100m) pharmaceutical factory in Vemgal, southern India. When fully operational …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
